Shares of Recursion Pharmaceuticals closed 23.88% higher on Friday, marking their best single-day gain in nearly two years.
Japan's SoftBank Group booked a surprise $2.4 billion quarterly loss on Wednesday, hit by a decline in the value of ...
SoftBank's telco arm remains strong despite challenges, but high-risk AI ventures and premium valuations pose significant ...
SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company’s revenue also missed analysts’ estimates.
SoftBank's latest investment of OpenAI values the company at $260B as its data center joint venture considers sites in 16 ...
SoftBank 99840.62%increase; green up pointing triangle Group reported a quarterly loss, partly due to the weakness in its technology funds business, as it geared up for a giant artificial ...
SoftBank Group posted a surprise quarterly loss Wednesday and the Japanese company’s revenue also missed analysts’ estimates.
SoftBank is close to finalize a $40 billion primary investment in OpenAI at a $260 billion valuation, CNBC reported on Friday ...
This debt is nonrecourse to SoftBank Group but gives a measure of leverage ... The purchase of ARM in 2016 and the subsequent attempt to sell it to Nvidia in 2020 which was rejected by regulators.
SoftBank Group OpenAI as a lead partners and we have ... And as technology partners, we have of course NVIDIA, Microsoft Oracle together with OpenAI those are the industry leaders is going to ...
Japanese tech investor SoftBank (SFTBF) swung to a $2.4 billion loss in the quarter ended December as valuations at its Vision Fund fell, ...